# NICHD SERVICE: PRODUCT AGNOSTIC SUPPORT FOR ADVANCING MULTIPURPOSE PREVENTION TECHNOLOGIES

> **NIH NIH N02** · PUBLIC HEALTH INSTITUTE · 2023 · $50,000

## Abstract

The NICHD Contraception Research Branch (CRB) is conducting research related to developing contraceptives technologies with anti-infective properties against pathogens such as HIV, Bacterial Vaginosis, Chlamydia, etc.
The objective of the order request is to obtain preclinical and/or clinical (e.g., Phase 1) multipurpose prevent technologies (MPT, contraceptives with anti-infective properties: e.g., anti-HIV) related consulting services for a range of product development considerations. This includes developing contraceptives technologies with anti-infective properties against pathogens such as HIV, Bacterial Vaginosis, Chlamydia, etc. supported by NICHD’s Contraception Research Branch. These services shall provide expert consultation to NICHD staff on pre-clinical, Phase 1 clinical, ethical, policy, and regulatory issues related to NICHD’s extramural contraceptive research portfolio and other related product development related areas, as directed by NICHD staff.

## Key facts

- **NIH application ID:** 10937100
- **Project number:** 75N94023P00844-0-0-1
- **Recipient organization:** PUBLIC HEALTH INSTITUTE
- **Principal Investigator:** NA NA
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $50,000
- **Award type:** —
- **Project period:** 2023-09-25 → 2024-09-24

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10937100

## Citation

> US National Institutes of Health, RePORTER application 10937100, NICHD SERVICE: PRODUCT AGNOSTIC SUPPORT FOR ADVANCING MULTIPURPOSE PREVENTION TECHNOLOGIES (75N94023P00844-0-0-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10937100. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*